Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-01-06

FDA Approved: SOLIFENACIN SUCCINATE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for solifenacin succinate from Actavis Pharma, Inc., authorizing a change related to this generic formulation. The appro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Solifenacin succinate (solifenacin)

Snippet

SUPPL AP for SOLIFENACIN SUCCINATE (SOLIFENACIN SUCCINATE)